MJ
Mirviss Jeffrey B. Vice-Président Exécutif et Président, Interventions Périphériques
Other M
US US · SEC (Form 4)
Browse the complete record of transactions filed by Mirviss Jeffrey B., Vice-Président Exécutif et Président, Interventions Périphériques. Director active across 1 companies, notably Boston Scientific CORP. Aggregated, 16 disclosures have been logged. Total volume traded: €2.4m. The latest transaction was disclosed on 20 April 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 16 total
€413,362 9,645 shares @ €42.8577 0.0003% mcap 17.4% of flow
Common Stock
SEC:0001225208-22-005987:0 · 20 Apr 2022
€463,200 10,989 shares @ €42.1512 0.0003% mcap 19.5% of flow
Common Stock
SEC:0001225208-22-005929:0 · 19 Apr 2022
€453,837 11,236 shares @ €40.3913 0.0003% mcap 19.1% of flow
Common Stock
SEC:0001225208-22-004996:0 · 22 Mar 2022
02,037 shares 0
Common Stock
SEC:0001225208-22-003863:0 · 28 Feb 2022
02,804 shares 0
Common Stock
SEC:0001225208-22-003082:0 · 21 Feb 2022
03,333 shares 0
Common Stock
SEC:0001225208-22-002922:0 · 17 Feb 2022
02,030 shares 0
Common Stock
SEC:0001225208-22-002677 · 15 Feb 2022
02,030 shares 0
Common Stock
SEC:0001225208-22-002677:0 · 15 Feb 2022
€263,493 6,840 shares @ €38.5223 0.0002% mcap 50.5% of flow
Common Stock
SEC:0001225208-22-000471 · 4 Jan 2022
€263,493 6,840 shares @ €38.5223 0.0002% mcap 11.1% of flow
Common Stock
SEC:0001225208-22-000471:0 · 4 Jan 2022
010,105 shares 0
Common Stock
SEC:0001225208-22-000114 · 1 Jan 2022
010,105 shares 0
Common Stock
SEC:0001225208-22-000114:0 · 1 Jan 2022
0183 shares 0
Common Stock
SEC:0001225208-21-014510 · 30 Aug 2021
0183 shares 0
Common Stock
SEC:0001225208-21-014510:0 · 30 Aug 2021
€258,091 6,748 shares @ €38.2471 0.0002% mcap 49.5% of flow
Common Stock
SEC:0001225208-21-010899 · 27 Jul 2021
€258,091 6,748 shares @ €38.2471 0.0002% mcap 10.9% of flow
Common Stock
SEC:0001225208-21-010899:0 · 27 Jul 2021
About Mirviss Jeffrey B. Mirviss Jeffrey B. is an executive at BOSTON SCIENTIFIC CORP.